NCT05828940View on ClinicalTrials.gov

Losartan and Memory

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
PTSD
Interventions
DRUG

Losartan Potassium

oral tablet, over-encapsulated

DRUG

Placebo

oral tablet, over-encapuslated

Trial Locations (1)

OX37JX

Department of Psychiatry, University of Oxford, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT05828940 - Losartan and Memory | Biotech Hunter | Biotech Hunter